Rare diseases
Investigational molecules
Locations
Back to Italy920 clinical trials in Treviso, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)Study on the Safety and Effects of Udonitrectag for Treating Diabetic Foot Ulcers in Patients
ItalyStudy on the Safety and Effectiveness of AL8326 for Patients with Small Cell Lung Cancer Needing Second-Line Treatment
ItalyStudy on the Effects of Tepotinib and Cetuximab for Patients with Platinum-Resistant Head and Neck Cancer After Immunotherapy Relapse
ItalyStudy on the Effectiveness of Deflazacort in Treating LMNA-related Congenital Muscular Dystrophy in Adults and Children
ItalyStudy on Niraparib for Patients with Advanced Urothelial Cancer After Initial Platinum Chemotherapy
ItalyStudy on the Safety and Effectiveness of Fludarabine and Treosulfan for Stem Cell Transplant in Acute Myeloid Leukemia Patients Aged 40 to 65
ItalyStudy on Alectinib for Patients with ALK+ Stage III Non-Small Cell Lung Cancer
ItalyStudy of Niraparib and Dostarlimab for Patients with Advanced Non-Small Cell Lung Cancer or Malignant Pleural Mesothelioma with Specific Genetic Mutations
ItalyStudy on Post-Surgery Treatment for Colon Cancer Patients Using Trifluridine, Irinotecan, and Drug Combination
ItalyStudy on Oxaliplatin and Capecitabine for Patients with Locally Advanced Rectal Cancer
ItalyStudy on the Effectiveness and Safety of INT230-6 (Vinblastine Sulfate, Cisplatin) for Adults with Metastatic Soft Tissue Sarcomas
ItalyStudy on the Safety of Argon and Oxygen Ventilation for Patients Resuscitated from Cardiac Arrest
ItalyThe busiest research cities in the country
What the registry says about research in the country
Innovative trials exploring treatments for Acute Myeloid Leukemia and Lymphomas, including studies on targeted therapies combined with standard chemotherapy. Research focuses on improving treatment outcomes for various blood cancers.
Advanced therapeutic approaches aim to enhance minimal residual disease control and patient outcomes.
Comprehensive research into ovarian cancer treatments, including studies of maintenance therapies and novel drug combinations. Investigations focus on both recurrent and newly diagnosed cases.
Studies emphasize personalized treatment approaches based on specific genetic markers and disease characteristics.
Groundbreaking research in lung cancer and severe respiratory conditions, including targeted therapies for specific genetic mutations and innovative treatment combinations.
Focus on developing personalized treatment strategies for various lung cancer subtypes and respiratory conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
